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Abstract 
 
Chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) was induced in 
Lewis rats by inoculation with guinea pig spinal cord and adjuvants and treatment with low 
dose cyclosporin A (CsA). Acute EAE was induced by the same method without CsA treatment. 
Immunocytochemistry and flow cytometry were used to assess inflammatory cells and MHC class 
II (Ia) antigen expression in the central nervous system of these rats. The inflammatory infiltrate 
was composed mainly of CD4+ T cells and macrophages, and αβ T cells constituted about 65% 
of the CD2+ T cells. After recovery from acute EAE and during the first remission of CR-EAE, 
the number of T cells was significantly less than in the preceding episodes. The number of T cells 
was higher in the second episode of CR-EAE than in the first remission. Throughout the course 
of CR-EAE, the majority of the CD2+ T cells were CD45RC−. The ratio of IL-2R+ cells to CD2+ 
cells ranged from 10.5 to 24.0%. The ratio of CD4+ T cells to B cells was lower in the later 
episodes of CR-EAE than in the first episode. Ia antigen was expressed on infiltrating round 
cells at all stages of CR-EAE and on microglial cells (identified by dendritic morphology) with 
increasing intensity throughout the course of CR-EAE. With flow cytometry, the number of Ia+ 
cells obtained from the spinal cord rose throughout the course of CR-EAE. The number of 
FSClowOX1low cells, which we consider represent microglia, also increased during the course of 
CR-EAE. 
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1. Introduction 
 
In the Lewis rat, experimental autoimmune encephalomyelitis (EAE) is usually an 
acute monophasic illness; chronic relapsing EAE (CR-EAE) can be induced by 
inoculation with guinea pig spinal cord and adjuvants and treatment with low dose 
cyclosporin A (CsA) (Polman et al., 1988). We have previously re-ported the 
neuropathological and electrophysiological findings in this model of CR-EAE 
(Pender et al., 1990; Stanley and Pender, 1991). The means by which low dose CsA 
causes CR-EAE is not known. Polman et al. (1988) suggested that suppressor 
mechanisms are inactivated by CsA, or that relapses are a rebound effect after 
cessation of the drug. In our study of chronic relapsing experimental autoimmune 
neuritis induced by inoculation with intradural root myelin and adjuvants and 
treatment with low dose CsA, we also suggested that low dose CsA treatment 
interferes with the regulatory mechanisms which prevent relapses (Mc-Combe et al., 
1990). One aim of the present study was to compare the immunopathology of acute 
EAE and CR-EAE, to search for effects of low dose CsA which might lead to 
relapses. 
A second aim was to study the inflammatory infiltrate in the CNS during the course of CR-
EAE, to determine whether it declined in clinical remission and intensified during relapse and 
whether the relative proportions of cells of different types varied through-out the course of 
CR-EAE. In the guinea pig (Traugott et al., 1982; Butter et al., 1989) and mouse (Traugott 
et al., 1986; Baker et al., 1990) models of CR-EAE, immunocytochemical studies have 
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demonstrated T cells and macrophages in the central nervous system (CNS). In CR-EAE 
induced in the Lewis rat by treatment with low dose CsA, Polman et al. (1988) found T 
cells and macrophages in the CNS 50 days after inoculation. In this model we have 
shown that each relapse is associated with inflammation and demyelination in the CNS 
(Pender et al., 1990). We have previously used immunocytochemistry and flow 
cytometry to study acute EAE induced by inoculation with myelin basic protein (MBP) 
(MBP-EAE) (McCombe et al., 1992). Such methods have not been used in CR-EAE, so 
in the present study we used a combination of immunocytochemistry and flow 
cytometry to assess inflammatory cells and MHC class II (Ia) antigen expression in the 
CNS throughout the course of CR-EAE. 
 
2. Materials and methods  
2.1. Animals 
 
Lewis rats (JC strain) were obtained from the Central Animal Breeding House of 
The University of Queensland. 
 
2.2. Preparation of inoculum and induction of EAE 
 
The inoculum consisted of a mixture of 1 g guinea pig spinal cord in 1 ml of 0.9% 
saline emulsified with 1 ml complete Freund's adjuvant (Difco) containing an additional 
10 mg Mycobacterium tuberculosis H37RA (Difco). As described previously (Pender et 
al., 1990), CR-EAE was induced by inoculation of Lewis rats with 0.05 ml inoculum 
into the medial footpad of the right hindfoot. Commencing on the day of inoculation, 
rats were given subcutaneous injections of cyclosporin A (Sandoz) 4 mg/kg on 3 days 
per week until day 21 after inoculation. Rats with acute EAE were inoculated as above 
but were not given CsA. 
 
2.3. Clinical assessment 
 
Tail, hindlimb and forelimb weakness were graded on a scale of 0 (no weakness) to 
4 (complete paralysis) as previously described (Pender, 1986). The total clinical score 
was obtained by adding the scores for the tail, hindlimbs and forelimbs. 
 
2.4. Monoclonal antibodies 
 
The following monoclonal antibodies were obtained from Serotec and by kind 
donation from Dr J. Sedgwick: R73 (αβ T cell receptor) (Hünig et al., 1989), OX34 
(CD2 on T cells and natural killer (NK) cells) (Williams et al., 1987), OX39 (IL-2R) 
(Paterson et al., 1987), OX22 (CD45RC, the high molecular mass form of the 
leukocyte common antigen on B cells, macrophages and some T cells) (Spickett et al., 
1983; Woollett et al., 1985), OX8 (CD8 on MHC class I restricted T cells and some 
NK cells) (Brideau et al., 1980), W3/25 (CD4) (White et al., 1978), OX33 (B cells) 
(Woollett et al., 1985), OX12 (kappa light chains) (Hunt and Fowler, 1981; Barclay, 
1981a), OX6 (MHC class II) (McMaster and Williams, 1979; Barclay, 1981b); OX42 
(CD11b) (Robinson et al., 1986) and OX1 (leukocyte common antigen on all cells of 
haemopoietic origin) (Sunderland et al., 1979). 
 
2.5. Immunostaining 
 
Rats were perfused with cold, isotonic saline. The spinal cord was removed and 
immediately frozen. Frozen sections (5 µm) from the lumbar and thoracic spinal cord 
and brainstem were collected on poly-L-lysine coated slides, air-dried, fixed in 
chloroform/acetone (1 : 1) and stored at –20°C until required. Endogenous peroxidase 
activity was blocked by 1% (w/v) phenylhydrazine. Sections were washed in 
phosphate-buffered saline (PBS) and incubated with normal rabbit serum. Sections 
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were washed in PBS, incubated with unconjugated primary mouse monoclonal anti-
body (ascites fluid) diluted 1:100 in PBS containing 20% foetal calf serum (FCS), 
washed, and exposed to peroxidase-conjugated rabbit anti-mouse immunoglobulin 
(Dakopatts). Sections were incubated with diaminobenzidine for 10-15 min. Sections 
without primary antibody were used as controls. Cells were regarded as positively 
stained if the cell outline was dark brown. 
 
2.6. Isolation of cells from the spinal cord 
 
Rats were perfused with cold, sterile, isotonic saline. Spinal cords were removed by 
insufflation, weighed, rinsed in Hank's balanced salt solution (HBSS) and passed 
through a 200-mesh stainless steel sieve and suspended in HBSS. Cells were isolated in 
a Percoll gradient using a modification of the method of Cohen et al. (1987). A two-
step discontinuous Percoll (Pharmacia) gradient was prepared by adding 10 ml isotonic 
Percoll to 24 ml spinal cord suspension and underlaying this 1.04 g/ml layer with 1.11 
g/ml Percoll solution. After centrifugation at 1500 × g for 30 min at 4°C, cells were 
collected from the 1.04-1.11 interface. 
 
2.7. Immunofluorescent labelling for flow cytometry 
 
100-µ1 aliquots of cells suspended in PBS, 10% normal rabbit serum were incubated 
with 100 µl monoclonal mouse anti-rat leukocyte primary antibody (Serotec ascites 
antibodies were diluted 1:100 and hybridoma supernatant antibodies obtained from Dr. 
J. Sedgwick were diluted 1: 30) for 30 min at 4°C or on ice. Cells were washed in 1 ml 
cold PBS, 1% FCS, 0.1% sodium azide and centrifuged at 600 × g for 5 min at 4°C. The 
wash solution was decanted and any excess blotted. The secondary antibody was a rat 
IgG-absorbed affinity purified F(ab')2 rabbit anti-mouse IgG phycoerythrin (PE) 
conjugate (Serotec). 50 µl secondary antibody diluted 1: 40 in PBS was added to the 
cells for 30 min at 4°C or on ice in the dark. Cells were washed as above. For two-
colour procedures 100 µl fluorescein-conjugated monoclonal antibody (diluted 1:100) 
was incubated with cells for 30 min at 4°C or on ice in the dark. Cells were washed as 
above and resuspended in 0.25 ml PBS, 1% FCS, 0.1% sodium azide and stored on ice 
in the dark prior to flow cytometric analysis. Control cells were incubated with 
secondary antibody only. 
 
2.8. Flow cytometry 
Single cell immunofluorescence analysis was performed using a FACScan flow 
cytometer and LYSYS II software (Becton Dickinson). For two-colour procedures, 
compensation settings corrected for the overlap of the emission spectra of fluorescein 
isothiocyanate (FITC) and PE. Except for the studies with normal rat spinal cord, where 
few cells were obtained, data were collected for 10,000 events. Debris and dead cells 
were excluded by gating. The numbers of positively labelled cell populations were 
calculated by subtracting the equivalent control values. The number of positively 
labelled cells/g spinal cord was calculated by multiplying the percentage of labelled 
cells by the yield of cells/g of spinal cord. To confirm that the cell population was 
composed of live cells, we used staining with fluorescein diacetate succinymidyl ester 
(CFSE) (Molecular Probes) with cells being incubated in 5 µM CFSE in PBS for 15 min 
at 37°C at a density of approximately 107 cells/ml and washed twice as previously 
described before analysis. Dead cells were assessed by staining with propidium iodide 
(PI). Cells were resuspended in 5 µg / ml  PI in PBS and placed on ice just prior to 
analysis. 
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TABLE 1 
Details of rats used in immunocytochemistry and flow cytometry 
 
Disease Number 
of rats 
Day after 
inoculation 
at time of 
study 
Mean ±  SD 
disability score 
when studied 
Mean ±  SD yield 
of cells from 
spinal cord (cells 
× 106g 
Rats studied by immunocytochemistry     
No CsA treatment     
  Acute EAE 5 12-14 6.2 ± 1.3  
  Recovery from acute EAE 1 20 1.0  
CsA treated     
  1st episode CR-EAE 5 12-14 7.4 ± 2.3  
  1st remission CR-EAE 5 18-20 0.4 ± 0.5  
  2nd episode CR-EAE 5 21-25 5.8 ± 1.6  
  Chronic persistent EAE 3 29-53 5.5 a  
     
Rats studied by flow cytometry     
Normal rats 5 − − 0.17 ± 0.07 
No CsA treatment     
  Acute EAE 5 10-13 6.6 ± 0.8 5.0 ± 1.9 
  Recovery from acute EAE 4 16-21 0 4.0 ± 2.0 
CsA treated     
  1st episode CR-EAE 5 12-14 6.7 ± 1.1 6.5 ± 1.0 
  1st remission off CR-EAE 5 18-21 0.2 ± 0.4 3.0 ± 1.0 
  2nd episode CR-EAE 5 21-23 7.6 ± 1.6 9.1 ± 3.6 
  3rd episode CR-EAE 5 26-34 7.2 ± 2.0 5.6 ± 1.4 
a This score is the mean of two rats. the third rat was moribund and the neurological assessment was considered to 
be unreliable. 
 
2.9. Statistical methods 
To compare the numbers of cells obtained from rats with acute EAE and rats in the 
first episode of CR-EAE we used Student's t-test. To make comparisons among the 
different stages of CR-EAE, we used analysis of variance (ANOVA), and performed 
post-analysis of variance calculations to obtain a Bonferroni P value, which is 
corrected for multiple comparisons, and which we have denoted as P*. Significance was 
taken to be P < 0.05. Non-significant results are denoted as NS. 
 
3. Results 
 
3.1. Clinical observations 
Inoculated rats that did not receive CsA usually had a single episode of acute EAE from which 
they recovered completely. As in our previous study (Pender et al., 1990), rats treated with low 
dose CsA developed CR-EAE, with most rats having at least three episodes of neurological 
signs separated by periods of remission, and a minority having persistent neurological signs of 
EAE (chronic persistent EAE) (Fig. 1). In general, the rats treated with low dose CsA had no 
further neurological episodes from about 40 days after inoculation. The clinical details of the 
rats in the present study are shown in Table 1. 
 
3.2. Immunocytochemical staining 
 
Normal rats 
Occasional Ia+ cells and occasional TCRαβ+ cells were seen in the meninges and around blood 
vessels of the spinal cord. In the parenchyma of the spinal cord, cells with dendritic 
Journal of Neuroimmunology (1994) 51 (2) : 153-167.           http://dx.doi.org/10.1016/0165-5728(94)90077-9 
morphology were weakly CD11b+ and weakly CD4+. 
Acute EAE (no CsA) 
 
Acute episode. The inflammatory infiltrate in the spinal cord and in the brainstem contained 
CD2+ cells (Fig. 2A) and CD11b+ round cells and was most prominent in the meningeal, subpial 
and perivascular regions. Many cells were CD4+. Few CDB+ cells, few IL-2R+ cells and few B 
cells were present. Some cells in the parenchymal inflammatory infiltrate were strongly 
CD45RC+. Many round cells and cells with dendritic morphology were Ia+. 
 
 
Fig. 1. Typical clinical courses of (A) a rat with acute EAE (B) a low dose cyclosporin A-treated rat with 
a chronic relapsing course of EAE and (C) a low dose cyclosporin A-treated rat with chronic persistent 
EAE. The clinical score was obtained by adding the scores for tail, hindlimb and forelimb weakness. The 
experiments in (B) and (C) were terminated by perfusion. 
 
Recovery from acute EAE. The number of infiltrating cells was considerably less than in the acute 
episode. There were occasional CD2+ cells in a subpial distribution. A few round cells in the 
white matter and many cells of dendritic morphology throughout the grey and white matter were 
CD11b+. Some CD45RC+ cells were present in the subpial regions, but few CD45RC+ cells 
were present in the parenchyma of the spinal cord. Ia expression was detected on cells of 
dendritic morphology throughout the spinal cord and on round cells in the white matter. 
 
CR-EAE (CsA-treated) 
 
First episode. There was a prominent subpial infiltrate with CD2+ cells and CD11b+ round cells 
(Fig. 2A). CD11b+ cells with dendritic morphology were also prominent. Many CD4+ round 
cells were present in the meninges and white matter. CD4+ cells with dendritic morphology 
were also seen. Few B cells or CDB+ cells were seen. CD45RC+ cells were present in the 
meninges, perivascular regions and in the parenchyma of the spinal cord. Many infiltrating 
round cells and also of cells with dendritic morphology were Ia+. Occasional IL-2R+ cells were  
seen. 
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Fig. 2. Immunoperoxidase staining of frozen sections from the spinal cord of rats with CR-EAE. (A) 
CD2+ round cells in the white matter of a rat in the first episode of CR-EAE, 14 days after inoculation. 
Bar represents 25 µm. (B) CD4+ cells in the spinal cord of a rat in the second episode of CR-EAE, 22 days 
after inoculation. Bar represents 25 µm. (C) OX22+ cells around a blood vessel and in adjacent white 
matter of a rat in the second episode of CR-EAE, 30 days after inoculation. Bar represents 25 µm. (D) Ia 
expression in the spinal cord of a rat with chronic persistent EAE, 29 days after inoculation. Bar represents 
25 µm. (E) CD11b+ cells in the spinal cord of a rat in the second episode of CR-EAE, 21 days after 
inoculation. Bar represents 25 µm. (F) CD11b+ cells around a blood vessel of a rat in the second episode of 
CR-EAE, 22 days after inoculation. Bar represents 25 µm. 
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First remission. The number of infiltrating cells was considerably reduced compared to that in 
the first episode. Many CD11b+ round cells and CD11b+ cells with dendritic morphology were 
present. CD2+ cells were present in the meninges and subpial regions and diffusely in the white 
matter, although the number was reduced compared to the first episode. Some CD45 RC+ cells 
were present around blood vessels but there were few CD45RC+ cells in the spinal cord 
parenchyma. There was Ia expression on clusters of round cells and on cells with dendritic 
morphology throughout the spinal cord. 
 
Second episode. The infiltrate was markedly increased compared to that in the first remission. 
There was a prominent infiltrate with CD2+ cells and CD11b+ round cells. CD1lb+ dendritic 
cells were also prominent (Fig. 2D, E). CD4+ round cells and CD4+ cells of dendritic 
morphology (Fig. 2B) were present. CD45 RC+ round cells were seen around the blood vessels 
(Fig. 2C) and also in the spinal cord parenchyma. Occasional B cells were seen in the subpial 
regions. There was marked Ia expression by round cells and cells with dendritic morphology. 
 
Chronic persistent EAE. Some CD2+ cells and CD11b+ round cells were seen. There was intense 
Ia expression throughout the spinal cord especially on cells with dendritic morphology, but also 
on round cells (Fig. 2F). Many cells with dendritic morphology were prominently CD11b+. 
 
3.3. Studies of cells extracted from the spinal cord 
Total number of cells extracted from the spinal cord  
The numbers of cells obtained from the spinal cord of different groups are shown in Table 1. In 
normal rats the mean yield was 0.17 ± 0.07 × 106/g spinal cord, whereas it was 5.0 ± 1.9 × 106/g 
in acute EAE and 6.5 ± 1.0 × 106/g in the first episode of CR-EAE. The total numbers of cells 
were less after recovery from acute EAE and in the first remission of CR-EAE than in the 
preceding episodes. In the second episode the mean yield rose significantly compared to the first 
remission ( P *  < 0.05). 
 
Flow cytometry studies 
 
Light scatter studies /identification of cells. By labelling with CFSE, which is cleaved by the 
intracellular enzymes of viable cells to release fluorescein, and with PI, which is excluded by 
viable cells, we confirmed that most of the events represented viable cells. In normal rats, the 
cells isolated from the spinal cord had low forward light scatter (FSC) and side light scatter 
(SSC). In rats with acute EAE and CR-EAE, as well as the FSClowSSClow cells obtained from 
normal rats we also observed cells with higher FSC and SSC. 
 
We studied the FSC and SSC of populations identified by labelling with different antibodies. 
The TCRαβ+ population comprised cells of intermediate size, but no small cells. The CD2+ 
population contained cells of intermediate size and also large cells that were not present in the 
TCRαβ + population. The CD4+ and the CD11b+ populations included small cells that were not 
present in the CD2+ or TCRαβ + populations. OX1+ cells fell into two populations, one with 
high FSC and high OX1 expression (FSChigh OX1high cells) and one with low FSC (similar to that 
of the small cells seen in the CD4+ and CD11b+ populations) and low OX1 expression 
(FSClowOX1low cells) (Fig. 3). We concluded (see Discussion) that these FSClowOX1low cells 
were microglia, as were the FSClowCD4+ cells and the FSClowCD11b+ cells. Double-labelling 
confirmed the presence of CD11b+ OX1high cells (macrophages), CD11b+OX1 low cells (mi-
croglia) and CD11b−OX1high cells (haematogenous cells other than macrophages). 
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T cells, T cell subsets and B cells. The numbers of lymphocytes of different subsets are shown in 
Table 2. The majority of lymphocytes were T cells. The numbers of CD2+ cells, TCRαβ +  
cells and IL-2R+ cells are shown in Fig. 4. After recovery from acute EAE and in the first 
remission of CR-EAE the numbers of CD2+ cells fell significantly compared to the preceding 
episodes ( P  < 0.05). The numbers of TCRαβ +  and IL-2R+ cells were less after recovery from 
acute EAE and in the first remission of CR-EAE than in the preceding episodes. In the second 
episode of CR-EAE, the numbers of CD2+ cells and TCRαβ + cells were greater than in the 
first episode but these differences were not statistically significant. In the third episode, the 
numbers of CD2+ cells and TCRαβ + cells were less than in the first and second episodes. 
There was no significant change in the numbers of IL-2R+ cells in the second and third 
episodes compared to that in the first episode. The ratios of the numbers of TCRαβ + cells to 
CD2+ cells and of IL-2R+ cells to CD2+ cells did differ significantly between the groups. 
CD4+ T cells were the predominant subset in all groups of rats (Table 2). In acute 
EAE and in the first episode of CR-EAE, the numbers of CD4+ T cells were 1.04 ± 0.40 and 
0.91 ± 0.22 cells × 106/g, respectively. After recovery from acute EAE and in the first 
remission of CR-EAE, the mean numbers of CD4+ T cells were 29% and 18%, respectively, 
of those in the preceding episodes. In the second episode of CR-EAE the number of CD4+ T 
cells was less than that in the first episode, although this was not statistically significant, 
while in the third episode it declined further. CD8+ cells were in the minority of T cells at all 
stages of acute EAE and CR-EAE (Table 2). The numbers of CD8+ cells were lower after 
recovery from acute EAE and in the first remission of CR-EAE than in the previous episodes 
(NS; P* < 0.05, respectively). The ratio of CD4+ T cells to CD8+ cells was 9.1 + 2.9 in acute 
EAE and 9.7 ± 4.1 in the first episode of CR-EAE and did not change significantly throughout 
the course of CR-EAE. The numbers of OX33+ and OX12+ cells (B cells) (Table 2) were low 
at all stages of EAE but were highest in the second episode of CR-EAE. The ratio of CD4+ T 
cells to B cells was 9.7 ± 3.9 in the first episode of CR-EAE and 2.6 ± 0.6 in the second 
episode and this difference was significant ( P *  < 0.05). In the third episode the ratio was 5.3 
± 4.6. 
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Table 2 (cont'd) 
 
 
 
 
CD45RC expression on T cells. To examine CD45RC expression on T lymphocytes we used dual 
labelling with OX22 and either OX34 or R73. We used accepted criteria (Bell and Sparshott, 
1990; Sparshott et al., 1991) to identify OX22− cells as having fluorescence at the level of 
control antibody binding and OX22bright cells as having the same level of OX22 fluorescence 
as B cells. There were also cells with intermediate levels of fluorescence which are described 
as OX22dim cells (Fig. 3). We included both OX22bright and OX22dim cells in the OX22+ cells. 
Double labelling with OX33 and OX22 was employed to establish the level of OX22 
fluorescence by B cells. 
 
 
 
 
Fig. 3. Upper panel: Flow cytometry analysis of OX1 expression and -forward light scatter (FSC) of 
cells extracted from the spinal cord of a rat with CR-EAE. Two populations are shown. One population 
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(arrow) is FSClowOX1low and we consider this population represents microglia (see Discussion). The other 
population is FSChighOX1high and includes macrophages and lymphocytes. As there is some over-lap of OX1 
expression between the two populations, we used FSC as well as OX1 expression to help define the two 
populations. Lower panel: OX22 (CD45RC) fluorescence of lymphocytes obtained from the spinal cord of a 
rat with acute EAE. There is a peak of low fluorescence (0X22−cells) and a peak of high fluorescence 
(OX22bright cells). There are also some cells at intermediate levels of fluorescence which are described as 
OX22dim (Bell and Sparshott, 1990; Sparshott et al., 1991). We included both OX22dim and OX22bright cells in 
the OX22+ group. 
 
 
 
 
Fig. 4. Numbers of T cells of different types obtained from the spinal cord in acute EAE (upper panel) and at 
different stages of CR-EAE (lower panel). The number of TCRαβ+ cells was less than the number of CD2+ 
cells at all stages of disease. The number of T cells of all types declined after recovery from acute EAE and 
during the first remission of CR-EAE. Many T cells were obtained from the spinal cord in the second 
episode of CR-EAE. (Rem = remission). 
 
Table 3 shows the frequency of CD45RC+CD2+ cells as a percentage of CD2+ cells and the 
frequency of CD45RC+TCRαβ + cells as a percentage of TCRαβ + cells at different stages of 
disease. At all stages of acute EAE and CR-EAE, the majority of T cells were CD45RC−. 
The mean proportion of CD2+ T cells that were CD45RC+ fell after recovery from acute EAE 
(P = 0.005), as did the proportion of TCRαβ + cells that were CD45RC+ (P = 0.04). The 
mean numbers of CD2+ and TCRαβ + cells that were CD45RC+ fell in the first remission of 
CR-EAE compared to the first episode, but not significantly. 
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TABLE 3 
CD45RC expression on T cells 
 
   CD45RC+CD2+/CD2+ (%)            CD45RC+TCRαβ +/TCRαβ+ (%) 
   Mean ± SD                    n      Mean ± SD                                     n 
 
Acute EAE     
  Acute episode 16.2 ± 3.6 5 10.2 ± 4.0 5 
  After recovery from acute EAE   8.3 ± 1.7 4   4.9 ± 1.0 4 
  Acute vs. recovery P = 0.005  P = 0.04  
     
CR-EAE     
  First episode 15.1 ± 2.3 5 11.7 ± 3.0 4 
  First remission 11.3 ± 1.3 3   6.9 ± 1.1 3 
  Second episode 14.7 ± 2.4 3   8.9 ± 2.1 5 
  Third episode 20.7 ± 4.3 5 17.0 ± 3.8 4 
 P* < 0.05 vs. 1st remission  P* < 0.05 vs. 1st remission 
P* < 0.05 vs. 2nd episode 
 
     
ANOVA (all CR-EAE) P = < 0.006  P = 0.04  
Acute EAE vs. first episode CR-EAE NS  NS  
 
 
Macrophages and microglia. To study macrophages and microglia we used labelling with 
OX42 and OX1 (Table 4). We measured the numbers of CD11b+ cells (macrophages and 
microglia), FSClowO X 1 low cells (microglia), and CD11b+ OX1high cells (macrophages). The 
total number of CD11b+ cells was the same in acute EAE and the first episode of CR-EAE 
and did not fall after recovery from acute EAE or in the first remission of CR-EAE. In the 
second episode of CR-EAE the mean number of total CD11b+ cells was greater than in the 
first episode ( P *  < 0.05) and in the first remission ( P *  < 0.01). In the third episode the 
number of CD11b+ cells was also higher than in the first episode of CR-EAE but this was 
not statistically significant. 
 
The number of CD11b+OX1high cells (macrophages) did not differ significantly between 
acute EAE and the first episode of CR-EAE and did not fall significantly after recovery from 
acute EAE or in the first remission of CR-EAE. The number of CD11b+ OX1high cells was 
higher in the second episode of CR-EAE than in the first remission ( P *  < 0.05) and in the 
third episode it was less than in the second episode ( P *  < 0.05). The percentage of CD11b+ 
cells that were OX1high cells fell significantly after recovery from acute EAE (P = 0.01). In 
CR-EAE, the percentage of CD11b+ cells that were OX1high declined progressively 
throughout the course of disease from 51.5% ± 27.6 in the first episode to 11.3% ± 2.6 in the 
third episode. This indicates that during the course of CR-EAE an increasing proportion of 
CD11b+ cells were OX1low (microglia). This was further analysed by studies of FSClow 
OX1 low cells (Table 4 and Fig. 5). The number of FSClow OX1low cells was similar in acute 
EAE and in the first episode of CR-EAE and did not change significantly after recovery 
from acute EAE or in the first remission of CREAE. In the second episode of CR-EAE the 
number of FSClow OX11ow cells was significantly higher than in the first remission and the 
first episode of CR-EAE ( P *  < 0.05 in each case) and in the third episode it remained high. 
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Fig. 5. Numbers of FSC low OX1 low cells (microglia) obtained from the spinal cord of rats with acute EAE 
and CR-EAE. The number of these cells increases throughout the course of CR-EAE. (Rem, remission). 
 
 
Ia+ (OX6+) cells. Table 4 shows the number of Ia+ cells at different stages of disease. The 
number of Ia+ cells was the same in acute EAE and in the first episode of CR-EAE and did 
not change significantly after recovery from acute EAE or in the first remission of CR-EAE. 
It was higher in the second episode of CR-EAE than in the first episode ( P *  < 0.01) and 
remained higher in the third episode. Ia expression was found on cells with both low FSC and 
high 
 
 
4. Discussion 
 
In the present study we used immunocytochemistry and flow cytometry to examine the 
inflammatory infiltrate and MHC class II (Ia) antigen expression in the CNS of Lewis rats 
with CR-EAE induced by inoculation with guinea pig spinal cord and treatment with low dose 
CsA (see Polman et al., 1988; Pender et al., 1990) and of Lewis rats with acute EAE. In acute 
EAE and in the first episode of CR-EAE the infiltrate was composed mainly of CD4+ T cells 
and macrophages. After recovery from acute EAE and in the first remission of CR-EAE the 
mean numbers of CD2+ cells, TCRαβ+ T cells, IL-2R+ cells, CD4+ T cells and CD8+ cells 
were less than half of those in the preceding episode. Previous studies have shown that few 
T cells remain in the CNS of Lewis rats (McCombe et al., 1992) and mice (Zeine and Owens, 
1993) that have recovered from acute EAE. To be lost from the spinal cord, cells may exit 
from the CNS or may die by apoptosis. We have described apoptosis of T lymphocytes in 
the spinal cord in acute MBP-EAE and suggested (Pender et al., 1991, 1992) that this 
apoptosis may contribute to the resolution of the CNS inflammation and possibly to resistance 
to re-induction of disease by re-inoculation (sec Willenhorg, 1979). FSC. 
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Rats after recovery from acute EAE were compared with rats in the first remission of CR-
EAE to look for effects of CsA treatment that might account for the development of relapses. 
We have hypothesized that treatment with CsA, which can inhibit activation-induced T cell 
apoptosis (Shi et al., 1989), prevents the apoptotic elimination of encephalitogenic T cells in 
the CNS (Pender, 1993). This might cause greater numbers of T lymphocytes to remain in the 
CNS of CsA treated rats in remission after the first episode of CR-EAE than in rats that have 
recovered from acute EAE; however, with the exception of TCRαβ + cells, which were more 
frequent in the rats recovered from acute EAE, there was no significant difference. Because 
only a minority of the T cells in the CNS in EAE are thought to be encephalitogenic (Smith and 
Waksman, 1969; Sedgwick et al., 1987) we cannot exclude the possibility that low dose CsA is 
blocking apoptosis of encephalitogenic T cells in the CNS. Low dose CsA could also inhibit 
activation-induced apoptosis of encephalitogenic T cells or their precursors in the thymus. 
Alternatively, low dose CsA treatment might cause relapses by selectively inhibiting 
downregulatory cells, such as the CD4+ transforming growth factor-n-producing cells described 
by Karpus and Swanborg (1991). 
To determine which cells are associated with relapses of EAE, we quantitated the infiltrating 
cells in the spinal cord in second and third episodes of CREAE and found increased numbers of 
T lymphocytes in the second episode of CR-EAE compared to the first remission, while in the 
third episode the number of T lymphocytes declined compared to that in the second episode. 
Polman et al. (1988) found T cells in the CNS in this model of CR-EAE 50 days after 
inoculation, but did not study rats throughout the course of CR-EAE. Immunocytochemical 
studies of CR-EAE in the guinea pig have demonstrated T cells in the spinal cord (Traugott et 
al., 1982; Antoniou et al., 1987a; Butter et al., 1989). In mice, immunocytochemical studies 
demonstrated CD4+ T cells in the CNS in relapses of CR-EAE (Traugott et al., 1986; Baker et 
al., 1990) and radio-labelling has demonstrated passively transferred cells in the nervous sys-
tem, especially in perivascular cuffs, in CR-EAE in SJL/J mice (Cross et al., 1990). These 
studies, together with the present study which clearly demonstrates an influx of CD4+ T cells 
into the CNS in the second episode of CR-EAE, suggest that CD4+ T cells, the effector cells in 
acute EAE (Pettinelli and McFarlin, 1981; Zamvil et al., 1985), continue to be important in 
relapses of CR-EAE. 
More CD4+ T cells than CD8+ cells were present in both acute EAE and the first episode of 
CR-EAE and the ratio did not change significantly throughout the course of disease. 
Matsumoto et al. (1993) found significantly more CD4+TCRαβ+ cells than CD8+ cells in 
extracts from the spinal cord of rats with MBP-EAE. Polman et al. (1988), using immunocyto-
chemistry, found approximately equal numbers of CD4+ and CD8+ cells in rats with CR-EAE. 
The role of CD8+ cells in EAE is unclear, but effector and immunoregulatory roles have been 
suggested. Mice which are genetically deficient in CD8+ cells have a milder initial episode of 
disease and develop spontaneous relapses of EAE (Koh et al., 1992). Mice depleted of CD8+ 
cells with antibody lose resistance to a second induction of EAE (Jiang et al., 1992), although 
earlier studies in mice and rats had shown no effect of anti-CD8 antibodies on the course of 
EAE (Waldor et al., 1985; Sedgwick et al., 1988). In the present study, the ratio of IL-2R+ cells 
to CD2+ cells did not change significantly throughout the course of CR-EAE. IL-2R expression 
occurs early and transiently after T cell activation (Smith, 1988). The IL-2R population may 
include the encephalitogenic T cells (Sedgwick et al., 1987). 
In acute EAE and throughout the course of CR-EAE, TCRαβ+ cells constituted about 65% 
of CD2+ cells. CD2+ TCRαβ+cells in the CNS in EAE could include γδ T cells, natural killer 
(NK) cells or cells which have down-regulated the expression of TCRαβ. γδ T cells have been 
found in the CNS in multiple sclerosis (Selmaj et al., 1991) and may be cytotoxic towards 
oligodendrocytes (Freedman et al., 1991). NK cells are large granular lymphocytes which 
might be predicted to have higher FSC and SSC than small lymphocytes. As our CD2+ 
population included cells of higher FSC and SSC than the TCRαβ+ cells we suggest that some 
of the CD2+ TCRαβ− cells may be NK cells. 
We studied the expression by CD2+ cells and TCRαβ+ cells of CD45RC, the high molecular 
mass form of the leukocyte common antigen. Our CD45RC+ and CD45RC− cells correspond to 
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the cells which are now described as CD45RChigh and CD45RClow by Mason and co-workers 
(Powric and Mason, 1990; Fowell et al., 1991) but which were initially described as CD45RC+ 
and CD45RC− (Powrie and Mason, 1989). CD45RC− T cells include memory cells (defined as 
having a strong response to recall antigens) (Ericsson et al., 1991) while CD45RC+ T cells 
include naive cells and probably some memory cells (Mason and Powrie 1990). CD45RC is 
lost after cell activation and cell division (Powrie and Mason, 1989, 1990; Deans et al., 1992), 
although it may be regained as a cell proceeds through the cell cycle (Bell and Sparshott, 1990; 
Yang and Bell, 1992). CD45RC expression has also been used to distinguish T cells with Th1-
like or Th2-like functions. In the rat, CD45RC+CD4+ T cells produce IL-2 and act in graft-
versus-host reactions (Powrie and Mason, 1988, 1989, 1990) and can be responsible for 
autoimmunity (Fowell et al., 1991) while some CD45RC− T cells are responsible for B cell 
help (Powrie and Mason, 1989) or can downregulate autoimmune disease (Fowell and Mason, 
1993). 
It is not clear whether CD45RC expression by T lymphocytes in the target organ in 
autoimmune disease is related to the activation status or functional capacity. In rats with acute 
EAE induced by inoculation with whole CNS tissue or MBP, the majority of the T cells in the 
spinal cord are CD4+CD45RC (Jensen et al., 1992; McCombe et al., 1992). In mice with acute 
EAE induced by the passive transfer of labelled, MBP-sensitized lymph node cells, the labelled 
cells in the CNS are CD45RBlow (equivalent to our CD45RC−) (Zeine and Owens, 1992). In the 
present study, at all stages of CR-EAE the majority of CD2+ T cells and TCRαβ+ T cells are 
CD45RC−. It is likely that the predominance of CD45RC− T lymphocytes in the CNS in CR-
EAE indicates that most of the infiltrating T cells have been activated. Activated 
encephalitogenic T cells and cells of other specificities can enter the normal CNS (Wekerle et 
al., 1986; Hickey et al., 1991) and the CNS in EAE (Ludowyk et al., 1992). 
To study B cells we used the OX33 antibody which labels a form of the leukocyte common 
antigen found on B cells but not on plasma cells (Pilarski and Jensen, 1992) and the OX12 
antibody which binds to kappa chains. The ratio of CD4+ T cells to B cells was less in the 
second and third episodes of CR-EAE than in the first episode. In a previous morphological 
study we found that plasma cells were prominent in the spinal cord in the later stages of this 
form of CR-EAE (Pender et al., 1990). Immunocytochemical studies have demonstrated many 
plasma cells and B cells in the CNS of guinea pigs with CR-EAE (Grundke-Igbal et al., 1980; 
Traugott et al., 1982; Bernheimer et al., 1988). As B cells can differentiate into plasma cells in 
target organs (Lee et al., 1992), antibody production in the CNS may contribute to the 
pathogenesis of CR-EAE, although circulating antibody also has a role (Linington and 
Lassmann, 1987; Linington et al., 1988; Gautam et al., 1991). Involvement of antibody could 
contribute to the prominent demyelination which occurs in the third episode of CR-EAE and in 
chronic persistent EAE (Pender et al., 1990). B cells might also act as antigen-presenting cells in 
the CNS. 
CD11b expression was used to identify macrophages and microglia. With 
immunocytochemistry, CD11b+ round cells (macrophages) were prominent at all stages of CR-
EAE. CD11b+ cells with dendritic morphology (microglia) were especially prominent in the 
later stages of CR-EAE, which could be due to increased expression of CD11b and/or an 
increase in the numbers of microglia. To assess numbers of microglia we used flow cytometry. 
Sedgwick and co-workers (1991) demonstrated that microglia can be isolated from the spinal 
cord of normal rats and rats with CNS inflammation and used a characteristically low 
expression of OX1 to identify microglia. In addition to low OX1 expression, we used FSC to 
identify microglia, because we consistently found a population of small cells in the CD4+ and 
the CD11b+ populations (which include microglia), but not in the CD2+ or TCRαβ+ populations. 
All cells extracted from the spinal cord fell either into a population of FSClow OX1low cells or a 
population of FSChigh OX1high cells (cells of haematogenous origin). We conclude that the 
FSClow OX1low cells represent microglia which are smaller than macrophages and lymphocytes 
(Milligan et al., 1991) and have a lower OX1 expression than haematogenously derived cells 
(Sedgwick et al., 1991). OX1 expression can be upregulated on microglia during CNS 
inflammation (Sedgwick et al., 1991) and there was some overlap of OX1 fluorescence between 
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our FSChigh OX1high and FSClow OX1low populations. We confirmed our interpretation by double 
labelling and found OX1low CD11b+ cells (microglia) and OX1high CD11b+ cells (macrophages). 
The number of microglia and the proportion of CD11b+ cells that are microglia increased in the 
later stages of CR-EAE. Sedgwick et al. (1991) suggested that microglia proliferate in 
inflammatory disease of the CNS, and Matsumoto et al. (1992a) found that microglia proliferate 
in acute EAE. We suggest that this proliferation continues in CR-EAE although we cannot 
exclude differentiation of infiltrating macrophages into microglia. 
With immunocytochemistry we observed Ia expression on round cells and cells of 
dendritic morphology in acute EAE and the first episode of CR-EAE. In the later episodes of 
CR-EAE, prominent Ia expression on cells of dendritic morphology was observed with im-
munocytochemistry, and increased numbers of Ia+ cells, including FSClow cells typical of 
microglia, were found with flow cytometry. In the CNS, Ia can be expressed on infiltrating 
lymphocytes, macrophages and microglia and has been widely described in acute EAE 
(Matsumoto et al., 1986; Vass et al., 1986; Konno et al., 1989; McCombe et al., 1992). In this 
model of CR-EAE, widespread Ia expression in the CNS was found 50 days after inoculation 
(Polman et al., 1988). In CR-EAE in the guinea pig, Antoniou et al. (1987b) found Ia 
expression on cells with dendritic morphology. Microglia can present antigen in vitro 
(Matsumoto et al., 1992b) and antigen presentation by Ia+ microglia could possibly play a role 
in the development of inflammation in CR-EAE. However, we observed widespread Ia 
expression on microglia throughout the spinal cord, including areas with little inflammation, 
which suggests that la expression by microglia does not necessarily lead to inflammatory 
infiltration. An alternative possibility is that, in EAE, microglial Ia expression occurs as 
a reaction to the disease. Widespread Ia expression occurs as a response to other 
conditions affecting the CNS such as ischaemia (Gehrmann et al., 1992), graft-versus-
host disease (Kajiwara et al., 1991) and distant trauma (Gehrmann et al., 1991). Such 
reactive Ia expression in EAE could play a role in downregulating the immune attack as, 
in mice, interferon-gamma (IFN-γ), which induces Ia expression, can suppress EAE 
(Billiau et al., 1988; Voorthuis et al., 1990) and antibodies to IFN-γ can enhance EAE 
(Billiau et al., 1988), and strains of rat that have constitutive Ia expression by microglia 
are resistant to the development of EAE (Sedgwick et al., 1993). We have proposed one 
possible mechanism by which MHC class II expression could downregulate disease 
which is that antigen presentation by non-specialised CNS antigen-presenting cells, that 
do not produce the co-stimulatory signal which is necessary for T cell activation 
(Jenkins et al. 1988), may lead to activation-induced apoptosis of encephalitogenic T 
cells (Pender et al., 1992; Pender, 1993). In the early stages of this model, CsA may 
protect from such apoptosis (see above) but after the cessation of CsA, activation-
induced apoptosis could contribute to the eventual resolution of CNS inflammation. 
In conclusion, we have studied CR-EAE in the Lewis rat and shown that T cells are 
present at all stages of disease, but have suggested a role for B cells in later stages of 
disease. The majority of T cells were CD45RC−, which probably indicates that these 
cells have been activated in the periphery or in the CNS. During the later episodes of 
CR-EAE there was a marked increase in Ia expression by microglia and increased 
numbers of microglia. 
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